Genome-wide analysis of multi-view data of miRNA-seq to identify miRNA biomarkers for stomach cancer

Stomach cancer is one of the leading causes of cancer-related deaths worldwide. More than 80% diagnosis of this cancer occur at later stages leading to low 5-year survival rate. This emphasizes the need to have better prognostic techniques for stomach cancer. In this regard, the Next-Generation Sequencing of whole genome and multi-view approach to omics may reveal the underlying molecular complexity of stomach cancer using high throughput expression data of miRNA. Generally, miRNAs are small, non-coding RNAs, which cause downregulation of target mRNAs. They also show differential expression for a specific biological condition like stage or histological type of stomach cancer, highlighting their importance as potential biomarkers. Analyzing miRNA expression data is a challenging task due to the existence of large number of miRNAs and less sample size. A small set of miRNAs will be helpful in designing efficient diagnostic and prognostic tool. In this regard, here a computational framework is proposed that selects different sets of miRNAs for five different categories of clinical outcomes viz. condition, clinical stage, age, histological type, and survival status. First, the miRNAs are ranked using four feature ranking methods. These ranks are used to find an ensemble rank based on adaptive weight. Second, the top 100 miRNAs from each category are used to find the miRNAs that are common to all categories as well as miRNAs that belong to only one category. Finally, the results have been validated quantitatively and through biological significance analysis.

[1]  S. Ivy,et al.  Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways , 2011, Nature Reviews Clinical Oncology.

[2]  M. Kanda,et al.  Review of recent efforts to discover biomarkers for early detection, monitoring, prognosis, and prediction of treatment responses of patients with gastric cancer , 2018, Expert review of gastroenterology & hepatology.

[3]  Na-Na Guan,et al.  Predicting miRNA‐disease association based on inductive matrix completion , 2018, Bioinform..

[4]  Hui Liu,et al.  Identifying Mammalian MicroRNA Targets Based on Supervised Distance Metric Learning , 2013, IEEE Journal of Biomedical and Health Informatics.

[5]  Avi Ma'ayan,et al.  Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool , 2013, BMC Bioinformatics.

[6]  Jiawei Luo,et al.  Inferring MicroRNA Targets Based on Restricted Boltzmann Machines , 2019, IEEE Journal of Biomedical and Health Informatics.

[7]  Masoud Soleimani,et al.  STAT3 is Overactivated in Gastric Cancer Stem-Like Cells , 2016, Cell journal.

[8]  Lei Wang,et al.  BNPMDA: Bipartite Network Projection for MiRNA–Disease Association prediction , 2018, Bioinform..

[9]  Artemis G. Hatzigeorgiou,et al.  DIANA-miRPath v3.0: deciphering microRNA function with experimental support , 2015, Nucleic Acids Res..

[10]  Gianluca Bontempi,et al.  On the Use of Variable Complementarity for Feature Selection in Cancer Classification , 2006, EvoWorkshops.

[11]  Qinbao Song,et al.  A new unsupervised feature selection algorithm using similarity‐based feature clustering , 2018, Comput. Intell..

[12]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[13]  Osamu Hirose,et al.  Inflammation in gastric cancer: Interplay of the COX‐2/prostaglandin E2 and Toll‐like receptor/MyD88 pathways , 2016, Cancer science.

[14]  Xing Chen,et al.  MicroRNAs and complex diseases: from experimental results to computational models , 2019, Briefings Bioinform..

[15]  E. Mardis The impact of next-generation sequencing technology on genetics. , 2008, Trends in genetics : TIG.

[16]  H. Xiao,et al.  MicroRNAs as potential biomarkers for gastric cancer. , 2014 .

[17]  P. Assumpção,et al.  MYC Deregulation in Gastric Cancer and Its Clinicopathological Implications , 2013, PloS one.

[18]  T. Wilson,et al.  Ets1 as a marker of malignant potential in gastric carcinoma. , 2003, World journal of gastroenterology.

[19]  R. Peek,et al.  Helicobacter pylori: gastric cancer and beyond , 2010, Nature Reviews Cancer.

[20]  Habibollah Haron,et al.  Supervised, Unsupervised, and Semi-Supervised Feature Selection: A Review on Gene Selection , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[21]  Min Rao,et al.  Knockdown of CREB1 inhibits tumor growth of human gastric cancer in vitro and in vivo. , 2017, Oncology reports.

[22]  Dahua Lin,et al.  Conditional Infomax Learning: An Integrated Framework for Feature Extraction and Fusion , 2006, ECCV.

[23]  F. Fleuret Fast Binary Feature Selection with Conditional Mutual Information , 2004, J. Mach. Learn. Res..

[24]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[25]  A. Jebaraj,et al.  Gastric cancer in India: epidemiology and standard of treatment , 2018, Updates in Surgery.

[26]  Dominik Heider,et al.  EFS: an ensemble feature selection tool implemented as R-package and web-application , 2017, BioData Mining.

[27]  Yue-Hua Jiang,et al.  Prognostic value of microRNAs in gastric cancer: a meta-analysis. , 2017, Oncotarget.